SCHEMBL4199776

SCHEMBL4199776

O=C(O)c1nn2c(c1OCc1ccccc1)C(=O)NCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HTT P42858 3/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ALOX5 P09917 1/20 0.35
POLB P06746 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC6A7 Q99884 1/20 0.34
GRM5 P41594 1/20 0.34
NR4A1 P22736 1/20 0.34
NR4A2 P43354 1/20 0.34
NR4A3 Q92570 1/20 0.34
P4HTM Q9NXG6 1/20 0.34
MCL1 Q07820 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18632628 0.93 ALOX5 (0.38) KDM4EALDH1A1HTTALOX5SLC6A7
SCHEMBL4199689 0.89 USP2 (0.43) ALDH1A1SMN1; SMN2USP2TSHRHSD17B10
SCHEMBL4356392 0.83 LMNA (0.47) ALDH1A1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL4198610 0.83 USP2 (0.44) ALDH1A1ALOX5SMN1; SMN2USP2TSHR
SCHEMBL4196395 0.77 GRM5 (0.42) KDM4EALDH1A1HTTNPC1RAB9A
SCHEMBL16270079 0.72 GRM5 (0.54) HTTALOX5GRM5
SCHEMBL4207607 0.72 LMNA (0.49) KDM4EALDH1A1HTTHRH3POLB
SCHEMBL12808331 0.71 POLB (0.40) POLBL3MBTL1TSHR
SCHEMBL4196385 0.68 LMNA (0.44) ALDH1A1SMN1; SMN2GRM5USP2TSHR
SCHEMBL19499516 0.67 HTT (0.46) ALDH1A1HTTALOX5POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758585-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-07-22 EP disclosed
US-7476666-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-01-13 US disclosed
US-20080015187-A1 Hiv Integrase Inhibitors MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed
EP-1758585-A2 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2007-03-07 EP disclosed
WO-2005120516-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015187-A1 Hiv Integrase Inhibitors REV1, ZC3HAV1, PNP KDM4E 1495/4885ALDH1A1 3490/4885HTT 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.